Crossmark

Early Trial Discontinuation in Toxicity-Driven, Dose-Escalating, Phase I Cancer Trials: Occurrence, Outcomes and Predictive Factors

Crossref DOI link: https://doi.org/10.1007/s40290-015-0120-8

Published Online: 2015-10-20

Published Print: 2016-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cousin, Sophie

Cassier, Philippe A.

Gomez-Roca, Carlos

Isambert, Nicolas

Kotecki-Borghesi, Nuria

Zanetta, Sylvie

Tassy, Louis

Simonet-Lamm, Anne-Laure

De Maio, Eleonora

Terret, Catherine

Bouchet, Juliette

Delord, Jean-Pierre

Penel, Nicolas
License Information

Text and Data Mining valid from 2015-10-20